Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03672396 · ClinicalTrials.gov registry record · NA
Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer
A NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT03672396 is a NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 22 participants, below the 216-participant average among 15 other Castration-resistant Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03672396, a NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
This single arm, multi-site pilot study aims to evaluate the feasibility of recruiting and adherence to a 12 week home-based exercise intervention to be conducted in men with metastatic castration resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Thirty patients will be enrolled, with the expectation that 20-25 will complete all follow-up measures.
Conditions Studied
Interventions
- BEHAVIORAL Home-based exercise
Study Locations (2)
North Carolina
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill - Chapel Hill
- Comprehensive Cancer Center, Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03672396
The ClinicalTrials.gov registry entry for NCT03672396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 216-participant average among 15 other Castration-resistant Prostate Cancer trials with a reported enrollment target (90% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Castration-resistant Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Home-based exercise is the first listed.
NCT03672396 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03672396 about?
NCT03672396 is a clinical study titled "Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer". This single arm, multi-site pilot study aims to evaluate the feasibility of recruiting and adherence to a 12 week home-based exercise intervention to be conducted in men with metastatic castration resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Thirty patients will be...
What is the current status of trial NCT03672396?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-04-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03672396 study?
This clinical trial studies the following conditions: Castration-resistant Prostate Cancer, Androgen Deprivation Therapy.
What interventions are being tested in trial NCT03672396?
The interventions under investigation include: Home-based exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03672396?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03672396 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Castration-resistant Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer
RECRUITING · Phase 2
-
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
RECRUITING
-
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
RECRUITING · Phase 1
-
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
RECRUITING · Phase 2
-
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
RECRUITING · Phase 1
-
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
RECRUITING · Phase 2
Explore more on PlainTrial
Castration-resistant Prostate Cancer
All registered trials for this condition
Androgen Deprivation Therapy
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.